stockrow

Screener

Quorum Health Corporation QHCQQ

Other — Other

Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.

Insider Decisions

in millions of $

	Nov 25			Feb 26			May 26			Aug 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership

31.47%

Capital & Financial Ratios

Market Cap

—

Revenue

1,590.61

Net Income

(202.81)

Free Cash Flow

(99.82)

Net Debt

1,251.93

Current Ratio

0.26

Debt/Equity

(4.08)

P/E ratio

0.00

P/S ratio

0.01

P/B ratio

0.00

Past 5Y EPS Growth

—

This Y EPS Growth

—

Next Y EPS Growth

—

Next 5Y EPS Growth

—

in millions of $

Dividends

Payout Ratio

—

Annual Dividend Rate

—

Annual Dividend Yield

—

	total	individual payouts
2021	‡‡‡
2020	‡‡‡
2019	‡‡‡

predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

	2017	2018	2019	Q'20
Cash	5.62	3.20	3.15	31.38
Receivables	343.15	322.61	286.90	270.83
Inventory	53.46	45.65	38.75	38.87
Other	152.75	99.85	60.64	62.40
	576.14	490.99	409.04	423.69

	2017	2018	2019	Q'20
Payables	171.25	143.92	156.67	163.27
ST’ Debt	1.86	1.70	1,211.49	1,262.74
Other	93.97	89.19	87.34	88.52
	355.34	321.73	1,550.79	1,627.11

in millions of $

Compound Annual Growth

	10y	5y	3y
Sales	—	‡‡‡‡‡	‡‡‡‡‡
Cash Flow	—	‡‡‡	‡‡‡
Earnings	—	‡‡‡	‡‡‡
Book Value	—	‡‡‡	‡‡‡

Revenue

	Mar	Jun	Sep	Dec	Year
’26	343.79	—	—	—	—
’19	442.81	442.17	419.90	384.75	1,689.63
’18	486.82	472.63	460.51	458.63	1,878.59
’17	527.64	530.15	499.30	515.08	2,072.17

in millions of $

Operating Cash Flow

	Mar	Jun	Sep	Dec	Year
’26	(8.74)	—	—	—	—
’19	8.08	(10.39)	25.16	(55.71)	(32.87)
’18	(2.59)	17.19	28.33	(3.43)	39.50
’17	18.53	(27.48)	9.74	66.18	66.97

in millions of $

Free Cash Flow

	Mar	Jun	Sep	Dec	Year
’26	(20.73)	—	—	—	—
’19	(1.40)	(22.54)	15.59	(72.15)	(80.50)
’18	(17.63)	5.87	18.28	(15.55)	(9.04)
’17	(6.20)	(45.07)	(4.79)	54.59	(1.46)

in millions of $

EPS

	Mar	Jun	Sep	Dec	Year
’26	(1.33)	(0.56)	(2.52)	—	—
’18	(3.48)	(0.92)	(1.85)	(0.71)	(6.91)
’17	(0.99)	(1.09)	(1.03)	(0.95)	(4.06)

Target Price Range

High

—

‡‡‡

Average

—

‡‡‡

Low

—

‡‡‡

Recommendation Rating

1
Buy

3
Hold

5
Sell

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
—	—	—	—	—	—	—	—	—	—	—	—	—	Low Price
—	—	—	—	—	—	—	—	—	—	—	—	—	High Price
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	Employees
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	Revenue/Emp
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	Revenue
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	Gross Margin
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	EBT
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	EBT Margin
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	Net Income
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	Depreciation
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	Revenue/Sh
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	Earnings/Sh
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡	‡‡‡	—	Cash Flow/Sh
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡	‡‡‡	—	Capex/Sh
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	Free CF/Sh
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡	‡‡‡	—	Book Value/Sh
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	Shares
—	—	—	—	—	—	‡‡‡	‡‡‡	‡‡‡	‡‡‡	‡‡‡‡	‡‡‡‡‡	—	PE Ratio
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	PS Ratio
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡	‡‡‡	‡‡‡	‡‡‡	—	PB Ratio
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	EV/Sales
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	EV/FCF
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡	‡‡‡	—	Op' Cash Flow
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡	‡‡‡	—	Capex
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡	‡‡‡	—	FCF
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	Working Cap'
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	Total Debt
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	Net Debt
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	Sh' Equity
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	ROA
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—	ROIC
—	—	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡	‡‡‡	—	ROE

predictions in italic, sparklines do not include predictions